IP Library › Granted Patent US 5,886,043
Granted Patent Utility
US 5,886,043 · App. 08/866,778

Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors

Inventors: Harold C. Kluender, Brian R. Dixon, Michael C. VanZandt, Scott Wilhelm, Donald J. Wolanin, William Bullock
Patented Case View Patent ↗
Granted: Mar 23, 1999 Filed: May 30, 1997
Inventors
Harold C. Kluender
Brian R. Dixon
Michael C. VanZandt
Scott Wilhelm
Donald J. Wolanin
William Bullock
Assignee (at issue)
Bayer Aktiengesellschaft

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 5,886,043
App. No.
08/866,778
Filed
1997-05-30
Granted
1999-03-23
Kind
A